PTEN公司
转录因子
癌
癌症研究
干扰素
甲状腺
肺
生物
病理
甲状腺癌
小细胞肺癌
肺癌
医学
内科学
小细胞癌
基因
内分泌学
细胞凋亡
遗传学
PI3K/AKT/mTOR通路
作者
Takuo Hayashi,Kazuya Takamochi,Yuka Yanai,Keiko Mitani,Hisashi Tomita,Kaoru Mogushi,Yoshiyuki Suehara,Fumiyuki Takahashi,Kenji Suzuki,Tsuyoshi Saito,Takashi Yao
标识
DOI:10.1016/j.humpath.2018.01.023
摘要
Here, we present a case of non–small cell lung carcinoma (NSCLC) with widespread and strong nuclear immunopositivity for both thyroid transcription factor-1 (TTF-1) and ΔNp63/p40 (p40). Double immunofluorescence for TTF-1 and p40 showed coexpression of both markers in the tumor cells. Furthermore, PTEN (pHis123Asp) and TP53 (pVal272Leu) mutations were identified as possible mitogenic driver mutations by next-generation sequencing. To the best of our knowledge, this is the first case of NSCLC harboring concurrent PTEN and TP53 mutations with widespread and strong coexpression of TTF-1 and p40, which has been confirmed in the resected specimen, and only the second documented case of NSCLC with TTF-1 and p40 diffuse coexpression in the carcinoma cells from the same individual. Our case illustrates the possibility that poorly differentiated NSCLCs with widespread and strong nuclear positivity for TTF-1 and p40 may be an underrecognized and new entity.
科研通智能强力驱动
Strongly Powered by AbleSci AI